LSIA
AZN icon

LaSalle St. Investment Advisors’s AstraZeneca AZN Stock Holding History

LaSalle St. Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$590K Buy
3,110
+330
+12% +$62.1K 0.07% 206
2026
Q1 		$548K Buy
2,780
+120
+5% +$23.1K 0.08% 187
2025
Q4 		$488K Buy
2,660
+81
+3% +$14.2K 0.08% 189
2025
Q3 		$395K Sell
2,579
-76
-3% -$11.5K 0.07% 205
2025
Q2 		$371K Buy
2,655
+360
+16% +$50.5K 0.1% 194
2025
Q1 		$337K Buy
2,295
+140
+6% +$20.3K 0.08% 203
2024
Q4 		$282K Buy
2,155
+525
+32% +$73.5K 0.09% 207
2024
Q3 		$254K Buy
1,630
+18
+1% +$2.91K 0.1% 167
2024
Q2 		$251K Buy
+1,612
New +$243K 0.13% 128

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LaSalle St. Investment Advisors's AZN Position: Q2 2026 in Review

LaSalle St. Investment Advisors increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $62.1K and bringing the position to 3,110 shares worth $590K. The position accounts for 0.07% of the portfolio, ranked #206.

LaSalle St. Investment Advisors first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • LaSalle St. Investment Advisors held 3,110 shares of AstraZeneca worth $590K as of Q2 2026.
  • LaSalle St. Investment Advisors bought 330 AstraZeneca shares in Q2 2026, an estimated $62.1K.
  • AstraZeneca made up 0.07% of LaSalle St. Investment Advisors's portfolio in Q2 2026, its #206 holding.
  • LaSalle St. Investment Advisors first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.